Why 22nd Century Group (XXII) Stock is Down Today 22nd Century Group (XXII) fell Monday after the tobacco breeder filed a Form S-3 shelf registration for $45 million with the SEC. The stock was down 10.14% to $2.48 at 1:03 p.m.
Full Answer
Is 22nd Century Group Inc’s stock down?
The 22nd Century Group Inc stock price fell by -4.15% on the last day (Monday, 14th Mar 2022) from $2.17 to $2.08. and has now fallen 3 days in a row. During the day the stock fluctuated 6.90% from a day low at $2.03 to a day high of $2.17. The price has fallen in 6 of the last 10 days and is down by -11.11% for this period.
Can 22nd century group help smokers quit?
The biotech wants to help smokers quit. Shares of 22nd Century Group ( XXII 5.50% ) soared 38.6% on Thursday after the U.S. Food and Drug Administration (FDA) authorized the company's VLN cigarette as a modified risk tobacco product (MRTP).
Is the stock in the middle of a falling trend?
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.48% during the next 3 months and, with a 90% probability hold a price between $1.42 and $2.35 at the end of this 3-month period.
How many shares were bought and sold in the last trade?
In the last 100 trades there were 8. 94 million shares bought and 2. 93 million shares sold. The last trade was done 76 days ago by Fleet Clifford B who sold 29. 55 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Will 22nd Century stock go up?
The 3 analysts offering 12-month price forecasts for 22nd Century Group Inc have a median target of 6.00, with a high estimate of 8.50 and a low estimate of 5.00. The median estimate represents a +219.15% increase from the last price of 1.88.
Is 22nd Century Group a good investment?
Valuation metrics show that 22nd Century Group, Inc may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of XXII, demonstrate its potential to underperform the market. It currently has a Growth Score of D.
When did XXII go public?
January 25th, 2011( XXII ) became public on January 25th, 2011 through a reverse merger with shell company Touchstone Mining Limited (source 21).
Why is XXII stock rising?
Indeed, news broke today that the FDA approved marketing for 22nd's reduced nicotine cigarettes. Consequently, XXII stock is up nearly 40% today on the promising news. 22nd Century announced that the FDA has authorized labeling its line of VLN King cigarettes as “modified risk tobacco products” (MRTPs).
Is XXII a buy or sell?
Barchart OpinionComposite IndicatorTrendSpotterSell20 - Day Average Volume: 1,463,135Average: 50% SellMedium Term Indicators50 Day Moving AverageSell15 more rows
Who owns 22nd century?
In 1998, Joseph Pandolfino founded 22nd Century Limited, LLC (22nd Century) to provide funding to North Carolina State University (NCSU) for research and development collaboration on nicotine biosynthesis in the tobacco plant. Mr.
What year does the 22nd century start?
January 1, 2101The 22nd century is the next century. It will begin on January 1, 2101 and will end on December 31, 2200.
Should I buy or sell 22nd Century Group stock right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last twelve months. There are currently 3 buy ra...
What is 22nd Century Group's stock price forecast for 2022?
3 brokerages have issued 12-month price targets for 22nd Century Group's stock. Their XXII stock forecasts range from $5.00 to $8.50. On average, t...
How has 22nd Century Group's stock performed in 2022?
22nd Century Group's stock was trading at $2.76 at the beginning of the year. Since then, XXII stock has decreased by 41.3% and is now trading at $...
When is 22nd Century Group's next earnings date?
22nd Century Group is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast for 2...
How were 22nd Century Group's earnings last quarter?
22nd Century Group, Inc. (NASDAQ:XXII) released its earnings results on Thursday, May, 5th. The biotechnology company reported ($0.05) earnings per...
Who are 22nd Century Group's key executives?
22nd Century Group's management team includes the following people: Mr. James A. Mish , CEO, Member of Scientific Advisory Board & Director (Age...
Who are some of 22nd Century Group's key competitors?
Some companies that are related to 22nd Century Group include Innovative Industrial Properties (IIPR) , MassRoots (MSRT) , Canopy Growth (WEED)...
What other stocks do shareholders of 22nd Century Group own?
Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Aurora Cannabis (...
What is 22nd Century Group's stock symbol?
22nd Century Group trades on the NASDAQ under the ticker symbol "XXII."
What happened
Shares of 22nd Century Group ( XXII -4.70% ) soared 38.6% on Thursday after the U.S. Food and Drug Administration (FDA) authorized the company's VLN cigarette as a modified risk tobacco product (MRTP).
So what
The agricultural biotechnology-specialist's VLN products contain 95% less nicotine than conventional cigarettes. But they taste and smell like the real thing, according to 22nd Century. Moreover, the FDA found that VLN can "help reduce exposure to, and consumption of, nicotine for smokers who use them."
Now what
Cigarette addiction is the leading cause of preventable disease in the U.S. Every year, over 480,000 people die from smoking-related illnesses. To save lives, the FDA is trying to give smokers more tools to help them quit.
Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development.
Support, Risk & Stop-loss
22nd Century Group Inc finds support from accumulated volume at $2.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is 22nd Century Group Inc stock A Buy?
22nd Century Group Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Insiders are positive buying more shares than they are selling in 22nd Century Group Inc
In the last 100 trades there were 8.94 million shares bought and 2.93 million shares sold. The last trade was done 58 days ago by Fleet Clifford B who sold 29.55 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
About 22nd Century Group Inc
22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
About 22nd Century Group
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions for life science, consumer product, and pharmaceutical markets.
22nd Century Group (NASDAQ:XXII) Frequently Asked Questions
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 22nd Century Group in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" 22nd Century Group stock. View analyst ratings for 22nd Century Group or view top-rated stocks.